GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
All Semaglutide Brands India
Generic SemaglutideType 2 Diabetes + Obesity
Torrent Pharmaceuticals logo

Sembolic/ SemalixGeneric semaglutide for type 2 diabetes + obesity in India 2026

by Torrent Pharmaceuticals · TBC (price band to be announced) · DCGI approved 2025

Active ingredient
Semaglutide (GLP-1 receptor agonist)
Indication
Type 2 Diabetes + Obesity
Manufacturer
Torrent Pharmaceuticals Ltd
DCGI status
Approved 2025
Price (MRP)
TBC (price band to be announced)
Format
Injectable + Oral
Injectable via Zydus license · Oral tablets (3 mg, 7 mg, 14 mg)
Prescription
Schedule H — required

How Sembolic compares

Sembolic is Torrent's brand of generic semaglutide and one of the few Indian launches to cover both injectable and oral formats. The injectable uses the Zydus reusable-pen platform under licence; the oral tablets are a generic equivalent of Novo Nordisk's Rybelsus. Sister brand Semalix runs in parallel commercial channels. Final pricing has not yet been published.

About Torrent Pharmaceuticals

Torrent Pharmaceuticals is one of India's top-fifteen pharma companies with a strong franchise in cardiology and gastroenterology. Co-marketing semaglutide via the Zydus device platform accelerates time-to-market while leveraging Torrent's specialist distribution.

Who is Sembolic for?

Sembolic is approved in India for both type 2 diabetes and chronic weight management in adults with obesity. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication). Patients with BMI ≥25 + comorbidities (PCOS, NAFLD, hypertension, sleep apnea) may also qualify under specialist judgment.

Not sure if you qualify? Take the 5-minute Indian-guideline eligibility check →

Sembolic for specific conditions

Sembolic for PCOS →Sembolic for fatty liver (NAFLD/MASLD) →Sembolic for hypertension + obesity →Sembolic for sleep apnea + obesity →

Sembolic cost in India

MRP for Sembolic: TBC (price band to be announced). Actual pharmacy pricing varies by city, pharmacy, and channel. Online prescription pharmacies typically offer modest discounts off MRP with cold-chain delivery; hospital pharmacy pricing is usually at MRP.

Compare with all India brands: GLP-1 therapy cost in India 2026 →

Compared to other GLP-1 brands in India

Sembolic is an Indian generic semaglutide. Same active molecule as Ozempic and Wegovy (Novo Nordisk innovator brands), with clinical efficacy that follows the molecule rather than the brand. Other Indian generics include Sundae, Noveltreat, Obeda, Semaglyn, Sembolic, and Samakind — all at similar price points.

All GLP-1 comparisons →All Indian semaglutide brands →Clinical evidence library →GLP-1 blog (India) →

Sembolic — frequently asked questions

Is Sembolic available in India? Is it DCGI-approved?+
Yes — Sembolic is DCGI-approved and currently available across India. The drug received DCGI approval in 2025 for both type 2 diabetes and obesity, manufactured by Torrent Pharmaceuticals Ltd. It is distributed through licensed retail and online prescription pharmacies and hospital pharmacies across Indian metros and most tier-2 cities. Sembolic is a Schedule H drug — a doctor's prescription is required. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
What does Sembolic cost in India in 2026?+
Sembolic is priced at TBC (price band to be announced). Actual pharmacy pricing may vary by city and channel. For brand-by-brand price comparisons across all India brands, see our cost guide. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Do I need a prescription to buy Sembolic?+
Yes — Sembolic is a Schedule H drug in India and can only be dispensed against a valid prescription from a registered medical practitioner. Any legitimate online prescription pharmacy will require you to upload your prescription before order fulfillment.
Who is Sembolic for?+
Sembolic is approved for both type 2 diabetes and obesity in India. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication), often with comorbidities at BMI ≥25. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
How does Sembolic compare to Ozempic and Wegovy?+
Sembolic contains the same active molecule (semaglutide) as Ozempic and Wegovy. Clinical efficacy is comparable; the difference is brand, manufacturer support, pen design, and price. Sembolic (TBC (price band to be announced)) is meaningfully cheaper than Ozempic (₹5,660+/month) or Wegovy (up to ₹16,400/month) — useful for cost-sensitive patients on long-term therapy.
Where can I buy Sembolic in India?+
Sembolic is a Schedule H drug — available through licensed retail and online prescription pharmacies and hospital pharmacies across India with a doctor's prescription. Always buy from a licensed pharmacy to avoid counterfeit products; never use sources that dispense without verifying a prescription. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.

Source

Business Standard — semaglutide generics overview

GLP-1 Check is informational, not a medical diagnosis. Semaglutide is a Schedule H drug in India and requires a prescription from a registered medical practitioner. Always consult a qualified physician before starting any treatment.

Are you eligible for Sembolic?

Take the free 5-minute triage to check your GLP-1 readiness against Indian clinical guidelines.

Check My Eligibility →

Looking at other brands?

See full price comparison across all 25+ DCGI-approved brands →